Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
20,707
archived clinical trials in
Gastrointestinal

Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  2/22/2013
Gastroenterology Associates of Osceola
811
mi
from 43215
Kissimme, FL
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Gastroenterology Associates of Osceola
811
mi
from 43215
Kissimme, FL
Click here to add this to my saved trials
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  2/22/2013
Sunrise Medical Research
966
mi
from 43215
Lauderdale Lakes, FL
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Sunrise Medical Research
966
mi
from 43215
Lauderdale Lakes, FL
Click here to add this to my saved trials
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  2/22/2013
Community Research Foundation
995
mi
from 43215
Miami, FL
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Community Research Foundation
995
mi
from 43215
Miami, FL
Click here to add this to my saved trials
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  2/22/2013
Paramount Public Health & Research Management Services
996
mi
from 43215
Miami, FL
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Paramount Public Health & Research Management Services
996
mi
from 43215
Miami, FL
Click here to add this to my saved trials
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  2/22/2013
Gastroenterology Group of Naples
957
mi
from 43215
Naples, FL
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Gastroenterology Group of Naples
957
mi
from 43215
Naples, FL
Click here to add this to my saved trials
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  2/22/2013
Clinical Research of West Florida
828
mi
from 43215
Clearwater, FL
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Clinical Research of West Florida
828
mi
from 43215
Clearwater, FL
Click here to add this to my saved trials
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  2/22/2013
Shafran Gastroenterology Center
791
mi
from 43215
Winter Park, FL
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Shafran Gastroenterology Center
791
mi
from 43215
Winter Park, FL
Click here to add this to my saved trials
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  2/22/2013
Atlanta Gastroenterology Specialists, PC
412
mi
from 43215
Suwanee, GA
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Atlanta Gastroenterology Specialists, PC
412
mi
from 43215
Suwanee, GA
Click here to add this to my saved trials
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  2/22/2013
Selah Medical Center
1715
mi
from 43215
Boise, ID
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Selah Medical Center
1715
mi
from 43215
Boise, ID
Click here to add this to my saved trials
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  2/22/2013
Northwest Gastroenterologists
296
mi
from 43215
Arlington Heights, IL
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Northwest Gastroenterologists
296
mi
from 43215
Arlington Heights, IL
Click here to add this to my saved trials
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  2/22/2013
Suburban Clinical Research
274
mi
from 43215
Chicago, IL
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Suburban Clinical Research
274
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  2/22/2013
University of Chicago Hospital
270
mi
from 43215
Chicago, IL
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
University of Chicago Hospital
270
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  2/22/2013
MediSphere Medical Research Center, LLC
277
mi
from 43215
Knight, IN
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
MediSphere Medical Research Center, LLC
277
mi
from 43215
Knight, IN
Click here to add this to my saved trials
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  2/22/2013
University of Iowa Hospitals and Clinics
460
mi
from 43215
Iowa City, IA
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
University of Iowa Hospitals and Clinics
460
mi
from 43215
Iowa City, IA
Click here to add this to my saved trials
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  2/22/2013
Cotton O'Neil Digestive Healthcare
676
mi
from 43215
Topeka, KA
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Cotton O'Neil Digestive Healthcare
676
mi
from 43215
Topeka, KA
Click here to add this to my saved trials
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  2/22/2013
University of Louisville
188
mi
from 43215
Louisville, KY
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
University of Louisville
188
mi
from 43215
Louisville, KY
Click here to add this to my saved trials
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  2/22/2013
Tufts Medical Center
642
mi
from 43215
Boston, MA
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Tufts Medical Center
642
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  2/22/2013
Brigham and Women's Hosp
643
mi
from 43215
Boston, MA
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Brigham and Women's Hosp
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  2/22/2013
University of Michigan Health Services
164
mi
from 43215
Ann Arbor, MI
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
University of Michigan Health Services
164
mi
from 43215
Ann Arbor, MI
Click here to add this to my saved trials
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  2/22/2013
Clinical Research Institute of Michigan, LLC
187
mi
from 43215
Chesterfield, MI
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Clinical Research Institute of Michigan, LLC
187
mi
from 43215
Chesterfield, MI
Click here to add this to my saved trials
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  2/22/2013
Beyer Research
210
mi
from 43215
Oshtemo, MI
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Beyer Research
210
mi
from 43215
Oshtemo, MI
Click here to add this to my saved trials
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  2/22/2013
Midwest Center for Clinical Research
608
mi
from 43215
Lees Summit, MO
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Midwest Center for Clinical Research
608
mi
from 43215
Lees Summit, MO
Click here to add this to my saved trials
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  2/22/2013
Center for Digestive & Liver Disease, Inc.
474
mi
from 43215
Mexico, MO
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Center for Digestive & Liver Disease, Inc.
474
mi
from 43215
Mexico, MO
Click here to add this to my saved trials
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  2/22/2013
Billings Clinic Research Center
1345
mi
from 43215
Billings, MT
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Billings Clinic Research Center
1345
mi
from 43215
Billings, MT
Click here to add this to my saved trials
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  2/22/2013
Quality Clinical Research, Inc.
688
mi
from 43215
Omaha, NE
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Quality Clinical Research, Inc.
688
mi
from 43215
Omaha, NE
Click here to add this to my saved trials
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  2/22/2013
Reno Clinical Trials
1936
mi
from 43215
Sparks, NV
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Reno Clinical Trials
1936
mi
from 43215
Sparks, NV
Click here to add this to my saved trials
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  2/22/2013
South Jersey Medical Associates, P.A.
421
mi
from 43215
Blackwood, NJ
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
South Jersey Medical Associates, P.A.
421
mi
from 43215
Blackwood, NJ
Click here to add this to my saved trials
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  2/22/2013
Holy Name Medical Center
477
mi
from 43215
Teaneck, NJ
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Holy Name Medical Center
477
mi
from 43215
Teaneck, NJ
Click here to add this to my saved trials
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  2/22/2013
Albany Medical College
515
mi
from 43215
Albany, NY
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Albany Medical College
515
mi
from 43215
Albany, NY
Click here to add this to my saved trials
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  2/22/2013
Digestive Health Physicians
300
mi
from 43215
Cheektowaga, NY
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Digestive Health Physicians
300
mi
from 43215
Cheektowaga, NY
Click here to add this to my saved trials
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  2/22/2013
Long Island Clinical Research Associates, LLP
492
mi
from 43215
Great Neck, NY
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Long Island Clinical Research Associates, LLP
492
mi
from 43215
Great Neck, NY
Click here to add this to my saved trials
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  2/22/2013
Metropolitan Research Associates
477
mi
from 43215
New York, NY
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Metropolitan Research Associates
477
mi
from 43215
New York, NY
Click here to add this to my saved trials
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  2/22/2013
Univ of North Carolina
353
mi
from 43215
Chapel Hill, NC
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Univ of North Carolina
353
mi
from 43215
Chapel Hill, NC
Click here to add this to my saved trials
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  2/22/2013
Clinical Trials Of America, Inc.
307
mi
from 43215
Winston Salem, NC
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Clinical Trials Of America, Inc.
307
mi
from 43215
Winston Salem, NC
Click here to add this to my saved trials
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  2/22/2013
Consultants for Clinical Research Inc.
98
mi
from 43215
Cincinnati, OH
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Consultants for Clinical Research Inc.
98
mi
from 43215
Cincinnati, OH
Click here to add this to my saved trials
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  2/22/2013
The Ohio State University-Inflammatory Bowel Disease Ctr
2
mi
from 43215
Columbus, OH
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
The Ohio State University-Inflammatory Bowel Disease Ctr
2
mi
from 43215
Columbus, OH
Click here to add this to my saved trials
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  2/22/2013
Great Lakes Gastroenterology
148
mi
from 43215
Mentor, OH
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Great Lakes Gastroenterology
148
mi
from 43215
Mentor, OH
Click here to add this to my saved trials
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  2/22/2013
Gastroenterology United of Tulsa
750
mi
from 43215
Tulsa, OK
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Gastroenterology United of Tulsa
750
mi
from 43215
Tulsa, OK
Click here to add this to my saved trials
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  2/22/2013
Northwest Gastroenterology Clinic, LLD
2026
mi
from 43215
Portland, OR
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Northwest Gastroenterology Clinic, LLD
2026
mi
from 43215
Portland, OR
Click here to add this to my saved trials
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  2/22/2013
James J. Boylan Gastroenterology and Liver Diseases
405
mi
from 43215
Bethlehem, PA
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
James J. Boylan Gastroenterology and Liver Diseases
405
mi
from 43215
Bethlehem, PA
Click here to add this to my saved trials
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  2/22/2013
Shirish A. Amin, MD, PC
209
mi
from 43215
Indiana, PA
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Shirish A. Amin, MD, PC
209
mi
from 43215
Indiana, PA
Click here to add this to my saved trials
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  2/22/2013
University of Pittsburgh Medical Center
165
mi
from 43215
Pittsburgh, PA
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
University of Pittsburgh Medical Center
165
mi
from 43215
Pittsburgh, PA
Click here to add this to my saved trials
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  2/22/2013
Donald Guthrie Foundation for Education and Research
366
mi
from 43215
Sayre, PA
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Donald Guthrie Foundation for Education and Research
366
mi
from 43215
Sayre, PA
Click here to add this to my saved trials
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  2/22/2013
Cherry Tree Medical
174
mi
from 43215
Uniontown, PA
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Cherry Tree Medical
174
mi
from 43215
Uniontown, PA
Click here to add this to my saved trials
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  2/22/2013
Omega Medical Research
615
mi
from 43215
Warwick, RI
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Omega Medical Research
615
mi
from 43215
Warwick, RI
Click here to add this to my saved trials
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  2/22/2013
Vanderbilt University Medical Center
333
mi
from 43215
Nashville, TN
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Vanderbilt University Medical Center
333
mi
from 43215
Nashville, TN
Click here to add this to my saved trials
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  2/22/2013
Lovelace Scientific Resources, Inc.
1065
mi
from 43215
Austin, TX
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Lovelace Scientific Resources, Inc.
1065
mi
from 43215
Austin, TX
Click here to add this to my saved trials
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  2/22/2013
Austin Gastroenterology PA/Professional Quality Research, Inc.
1065
mi
from 43215
Austin, TX
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Austin Gastroenterology PA/Professional Quality Research, Inc.
1065
mi
from 43215
Austin, TX
Click here to add this to my saved trials
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  2/22/2013
Diagnostic Clinic of Houston
991
mi
from 43215
Houston, TX
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Diagnostic Clinic of Houston
991
mi
from 43215
Houston, TX
Click here to add this to my saved trials
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  2/22/2013
Baylor College of Medicine
991
mi
from 43215
Houston, TX
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Baylor College of Medicine
991
mi
from 43215
Houston, TX
Click here to add this to my saved trials